Security · CUSIP 00182CAC7
ANI PHARMACEUTICALS INC
NOTE 2.250% 9/0 · institutional ownership from 13F filings
13F holders
4
Shares held
27.5M
Value held
$50.5M
New / sold out
1 / 1
Added / reduced
1 / 1
net +11.1M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q1 2026
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management L.P. | 15,000,000 | $18.6M | 0.02% |
| Boussard & Gavaudan Investment Management LLP | 13,350 | $16.5M | 4.09% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 11,473,000 | $14.2M | 0.40% |
| Bank of New York Mellon Corp | 1,000,000 | $1.2M | 0.00% |
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| Balyasny Asset Management L.P. | New | +15,000,000 | – |
| Bank of New York Mellon Corp | Added | +150,000 | +17.6% |
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| PICTON MAHONEY ASSET MANAGEMENT | Sold out | -4,000,000 | -100.0% |
| Boussard & Gavaudan Investment Management LLP | Reduced | -5,150 | -27.8% |